North American Prescription Price Equity Act of 2003

Summary

Official

North American Prescription Price Equity Act of 2003 - Amends the Internal Revenue Code to allow drug manufacturers a limited tax credit if they certify that the wholesale price of a drug in the United States market is not greater than its wholesale price in the Canadian or Mexican market.

How would you vote on this bill?

Yes No

Bill Progress

Bill has been introduced and assigned a number

Introduced(1/27/03)

Committee

Passed House

Passed Senate

President

Law